Developing an Algorithm To Analyze Structural Characteristics of Alzheimer's Disease in Different Stages of Mild Cognitive Impairment and Validate White Matter Atrophy as an Early Predictor of Mild Cognitive Impairment (A Novel Second Year Study)
ISEF · 2022 Computational Biology and Bioinformatics
Overview
Alzheimer’s disease (AD) is the sixth leading cause of death in the world, and has no method for prevention or effective treatment. A promising method of predicting it is through analyzing the structural MRIs of mild cognitive impairment (MCI) patients. Diagnosing MCI can be subjective, but using an automated method can lead to an earlier diagnosis of AD, higher quality of life, and lower healthcare costs. The purpose of this experiment was to determine the validity of white matter atrophy as a characteristic of MCI and Alzheimer’s disease and use that to develop an algorithm to differentiate between cognitively normal patients, patients with Alzheimer’s disease, and patients with differing severities of MCI. The researcher considered five factors: age, sex, hippocampal, white matter, and total brain volume. White matter atrophy was found to be a significant structural characteristic of Alzheimer’s disease in comparison with hippocampal and total brain atrophy. The algorithm established risk factors based on volume of the hippocampal formation, white matter structures, and total brain for patients of specific age groups and sexes. Analysis of scans showed that destruction of white matter structures is more prevalent before hippocampal atrophy and eventually, total brain atrophy, which supports evidence for white matter atrophy being a reliable indicator of MCI. The algorithm was trained with 1,100 pieces of data and then tested with 110, yielding an accuracy of 91%. With further testing, this may be a promising tool for differentiating between cognitively normal, eMCI, MCI, lMCI, and AD patients.
Competition history
- ISEF 2022
Resources
Related projects
ISEF · 2020
Developing a Pre-Risk Assessment Incorporating Machine-Learning and Biomarkers to Diagnose Alzheimer's Disease
ISEF · 2022
A Novel Approach to Analyzing Alzheimer's Disease in MRI Scans Using a Convolutional Neural Network
CSEF · 2015
ALZCan: Predicting Future Onset of Alzheimer's Using Gender, Genetics, Cognitive Tests, CSF Biomarkers, and Neuroimaging
ISEF · 2024
Beyond Scans: Predicting Alzheimer's Through MRI and Handwriting Analysis
ISEF · 2024
Alzheimer's Recognition Using Artificial Intelligence
CSEF · 2019
Implementation and Validation of a Machine Learning Model for the Early Detection of Alzheimer's Disease
ISEF · 2018
Alzheimer's Disease Prediction
ISEF · 2022
A Novel Approach for Early Detection of Alzheimer's Disease: Developing an AlexNet Convolutional Neural Network Enhanced by Class Activation Mapping
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: Regeneron International Science and Engineering Fair